Oncolytics Biotech (ONCY) Non-Current Assets (2009 - 2025)

Oncolytics Biotech (ONCY) has 17 years of Non-Current Assets data on file, last reported at $738000.0 in Q4 2025.

• On a quarterly basis, Non-Current Assets fell 21.42% year-over-year to $738000.0 in Q4 2025; TTM through Dec 2025 was $3.1 million, a 22.52% decrease from a year earlier, with the FY2025 full-year figure at $738000.0, down 22.99% from the prior year.
• Non-Current Assets for Q4 2025 stood at $738000.0, up from $730994.8 in the prior quarter.
• Over the last five years, Non-Current Assets for ONCY reached as high as $1.2 million in Q4 2022 and fell as low as $475244.5 in Q4 2023.
• Historically, Non-Current Assets has averaged $786438.5 across 5 years, with a median of $756148.0 in 2021.
• Across the five-year window, Non-Current Assets slumped 60.9% in 2023 and jumped 97.62% in 2024, its largest moves.
• Year by year, Non-Current Assets stood at $774296.0 in 2021, then surged by 56.99% to $1.2 million in 2022, then plunged by 60.9% to $475244.5 in 2023, then soared by 97.62% to $939194.1 in 2024, then decreased by 21.42% to $738000.0 in 2025.
• Per Business Quant data, the three most recent Non-Current Assets figures were $738000.0 in Q4 2025, $730994.8 in Q3 2025, and $778006.1 in Q2 2025.